SCINAI IMMUNOTHERAPEUTICS LTD. Profit Loss
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Profit Loss of -ILS 12.85 million for the 3-month period ending 2022-06-30, per its 6-K/A filed 2022-08-29.
Discontinued › Income Statement › Net Income
ifrs-full:ProfitLoss · last filed 2022-08-29
- SCINAI IMMUNOTHERAPEUTICS LTD. profit loss for the quarter ending 2022-06-30 was -12.85M ILS.
- SCINAI IMMUNOTHERAPEUTICS LTD. profit loss for the quarter ending 2021-12-31 was -10.75M ILS.
- SCINAI IMMUNOTHERAPEUTICS LTD. profit loss for the quarter ending 2021-09-30 was -9.05M ILS, a 116.35% decline year-over-year.
- SCINAI IMMUNOTHERAPEUTICS LTD. profit loss for the quarter ending 2021-06-30 was -11.99M ILS.
ILS
| Period end | Profit Loss 3 month | Profit Loss 6 month | Profit Loss 9 month | Profit Loss 12 month |
|---|---|---|---|---|
| 2022-06-30 | -12.85M ILS 6-K/A · filed 2022-08-29 | -22.27M ILS 6-K/A · filed 2022-08-29 | ||
| 2021-12-31 | -10.75M ILS derived: 6-K/A 12 month − 6-K/A 9 month · filed 2022-08-29 | -19.80M ILS derived: sum of 2 quarters · filed 2022-08-29 | -31.79M ILS derived: sum of 3 quarters · filed 2022-08-29 | -39.98M ILS 6-K/A · filed 2022-08-29 |
| 2021-09-30 | -9.05M ILS 6-K/A · filed 2021-12-27 | -21.04M ILS derived: sum of 2 quarters · filed 2022-08-29 | -29.23M ILS 6-K/A · filed 2021-12-27 | |
| 2021-06-30 | -11.99M ILS 6-K/A · filed 2022-08-29 | -20.18M ILS 6-K/A · filed 2022-08-29 | ||
| 2020-12-31 | -14.10M ILS derived: 20-F 12 month − 6-K/A 9 month · filed 2022-03-28 | 41.22M ILS derived: sum of 2 quarters · filed 2022-03-28 | -760.00K ILS derived: sum of 3 quarters · filed 2022-03-28 | -4.46M ILS 20-F · filed 2022-03-28 |
| 2020-09-30 | 55.31M ILS 6-K/A · filed 2021-12-27 | 13.34M ILS derived: sum of 2 quarters · filed 2021-12-27 | 9.64M ILS 6-K/A · filed 2021-12-27 | |
| 2020-06-30 | -41.98M ILS 6-K · filed 2020-10-02 | -45.67M ILS 6-K · filed 2020-10-02 | ||
| 2019-12-31 | -43.02M ILS derived: 20-F 12 month − 6-K 9 month · filed 2022-03-28 | -62.37M ILS derived: sum of 2 quarters · filed 2022-03-28 | -109.76M ILS derived: sum of 3 quarters · filed 2022-03-28 | -109.19M ILS 20-F · filed 2022-03-28 |
| 2019-09-30 | -19.36M ILS 6-K · filed 2021-01-28 | -66.74M ILS derived: sum of 2 quarters · filed 2021-01-28 | -66.18M ILS 6-K · filed 2021-01-28 | |
| 2019-06-30 | -47.39M ILS 6-K · filed 2020-10-02 | -46.82M ILS 6-K · filed 2020-10-02 | ||
| 2018-12-31 | -87.73M ILS 20-F · filed 2021-05-13 | |||
| 2017-12-31 | -34.55M ILS 20-F · filed 2020-06-12 | |||
| 2016-12-31 | -9.18M ILS 20-F · filed 2019-04-30 | |||
| 2015-12-31 | -10.20M ILS 20-F · filed 2018-04-30 |
USD
| Period end | Profit Loss 3 month | Profit Loss 6 month | Profit Loss 9 month | Profit Loss 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$6.36M 6-K/A · filed 2022-08-29 | |||
| 2021-12-31 | -$3.80M derived: 20-F 12 month − 6-K/A 9 month · filed 2022-03-28 | -$12.85M 20-F · filed 2022-03-28 | ||
| 2021-09-30 | -$9.05M 6-K/A · filed 2021-12-27 | |||
| 2020-12-31 | -$1.39M 20-F · filed 2021-05-13 | |||
| 2017-12-31 | -$9.97M 20-F · filed 2018-04-30 |